ED Coding & Reimbursement Alert - 2004 Issue 42
Coverage: Medicare Announces New Cancer Drug Admin Codes
Subscribe or sign in to view the full article.
Article Overview
This article explains a Medicare payment update affecting oncology practices, including the introduction of new physician administration codes for anti-cancer drugs and the related policy review process. It is relevant to oncologists, medical coders, billing staff, and others tracking Medicare reimbursement changes. The discussion focuses on how the new administration codes fit into broader changes to cancer drug payment methodology and professional concerns about payment impact.
Why This Topic Matters
Cancer drug reimbursement changes can affect both practice operations and Medicare payment planning for oncology services. Understanding the scope of the new administration codes helps readers track policy developments that may influence physician billing and revenue.
What You Will Learn
- How Medicare is changing payment for cancer drug administration
- Why oncology groups were focused on administration reimbursement
- How the new payment review process relates to broader Medicare drug payment policy
- Why organizations were evaluating the likely financial impact of the changes
Who Should Read This
- Oncologists
- Medical coders
- Medical billers
- Practice administrators
- Healthcare reimbursement analysts
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com